Development code · Small Molecule
ITI-214
ITI-214 is a development code for Lenrispodun (ITI-214), developed by Intra-Cellular Therapies, Inc..
- Status
- Phase 2 for Parkinson's disease
- Mechanism
- PDE1B Inhibitor
- Developer
- Intra-Cellular Therapies, Inc.
Programs
- Lenrispodun (ITI-214) for Parkinson's diseasePhase 2Active
Also known as
- IC-200214
- Lenrispodun
- 1160521-50-5